About MDxhealth (OTCMKTS:MXDHF)
MDxHealth SA, a molecular diagnostics company, develops and commercializes epigenetic and other molecular tests for cancer assessment and the personalized treatment of patients in Belgium and internationally. The companys tests are based on genetic, epigenetic (methylation) and other molecular technologies, and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, and prediction of response to a specific therapy. The companys products include ConfirmMDx, a solution for prostate cancer testing; and SelectMDx, a pre-biopsy diagnostic tool for prostate cancer. Its product pipeline includes tests for bladder, kidney, and other urologic cancers. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was founded in 2003 and is headquartered in Herstal, Belgium.
Industry, Sector and Symbol
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Annual Sales$29.97 million
Price / Sales7.15
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on AssetsN/A
MDxhealth (OTCMKTS:MXDHF) Frequently Asked Questions
What is MDxhealth's stock symbol?
MDxhealth trades on the OTCMKTS under the ticker symbol "MXDHF."
Who are some of MDxhealth's key competitors?
Some companies that are related to MDxhealth include Voyager Therapeutics (VYGR), Insys Therapeutics (INSY), Aurinia Pharmaceuticals (AUPH), Enzo Biochem (ENZ), Kura Oncology (KURA), Nightstar Therapeutics (NITE), Cytokinetics (CYTK), Seres Therapeutics (MCRB), Cerus (CERS), Zealand Pharma A/S (ZEAL), Celldex Therapeutics (CLDX), Corium International (CORI), Oxford Biomedica (OXBDF), Celyad (CYAD), Computer Programs & Systems (CPSI), Achillion Pharmaceuticals (ACHN), SIGA Technologies (SIGA) and SurModics (SRDX).
How do I buy MDxhealth stock?
Shares of MDxhealth can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is MDxhealth's stock price today?
One share of MDxhealth stock can currently be purchased for approximately $4.30.
How big of a company is MDxhealth?
MDxhealth has a market capitalization of $214.34 million and generates $29.97 million in revenue each year.
How can I contact MDxhealth?
MDxhealth's mailing address is CAP Business Center Rue d`Abhooz 31, Herstal C9, 4040. The company can be reached via phone at 324-364-2070 or via email at [email protected]
MarketBeat Community Rating for MDxhealth (MXDHF)MarketBeat's community ratings are surveys of what our community members think about MDxhealth and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
MDxhealth (OTCMKTS:MXDHF) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Earnings History for MDxhealth (OTCMKTS:MXDHF)
No earnings announcements for this company have been tracked by MarketBeat.com
MDxhealth (OTCMKTS:MXDHF) Earnings Estimates
Current Year EPS Consensus Estimate: $-0.2 EPS
Next Year EPS Consensus Estimate: $-0.22 EPS
Dividend History for MDxhealth (OTCMKTS:MXDHF)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for MDxhealth (OTCMKTS MXDHF)
No insider trades for this company have been tracked by MarketBeat.com
MDxhealth (OTCMKTS MXDHF) News Headlines
No headlines for this company have been tracked by MarketBeat.com
MDxhealth (OTCMKTS:MXDHF) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
MDxhealth (OTCMKTS MXDHF) Stock Chart for Wednesday, December, 13, 2017